Karim Chamie

7.6k total citations · 1 hit paper
183 papers, 5.1k citations indexed

About

Karim Chamie is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Karim Chamie has authored 183 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Surgery, 68 papers in Pulmonary and Respiratory Medicine and 54 papers in Oncology. Recurrent topics in Karim Chamie's work include Bladder and Urothelial Cancer Treatments (104 papers), Urinary and Genital Oncology Studies (59 papers) and Prostate Cancer Diagnosis and Treatment (37 papers). Karim Chamie is often cited by papers focused on Bladder and Urothelial Cancer Treatments (104 papers), Urinary and Genital Oncology Studies (59 papers) and Prostate Cancer Diagnosis and Treatment (37 papers). Karim Chamie collaborates with scholars based in United States, Germany and Canada. Karim Chamie's co-authors include Andrew T. Lenis, Patrick M. Lec, Mark S. Litwin, Lorna Kwan, Alexandra Drakaki, Allan J. Pantuck, Christopher S. Saigal, Timothy J. Daskivich, Nicholas M. Donin and Badrinath R. Konety and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Karim Chamie

174 papers receiving 5.0k citations

Hit Papers

Bladder Cancer 2020 2026 2022 2024 2020 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bladder Cancer
    2020 1.1k citations Andrew T. Lenis, Patrick M. Lec et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karim Chamie United States 34 2.5k 1.7k 1.4k 1.3k 666 183 5.1k
Simon Tanguay Canada 40 2.1k 0.8× 2.4k 1.4× 1.5k 1.1× 816 0.6× 550 0.8× 213 4.7k
Howard Kynaston United Kingdom 32 1.2k 0.5× 1.3k 0.7× 1.2k 0.9× 914 0.7× 601 0.9× 111 4.0k
C.C. Abbou France 40 2.3k 0.9× 2.5k 1.5× 2.0k 1.5× 678 0.5× 684 1.0× 139 5.0k
Louis Denis United States 29 2.3k 0.9× 2.4k 1.4× 1.2k 0.9× 2.0k 1.5× 500 0.8× 98 5.8k
Robert S. Svatek United States 43 4.6k 1.8× 1.2k 0.7× 1.3k 1.0× 1.4k 1.1× 479 0.7× 211 6.2k
Theresa M. Koppie United States 32 2.4k 0.9× 1.3k 0.8× 1.2k 0.9× 909 0.7× 461 0.7× 71 4.2k
Gabriel P. Haas United States 37 1.6k 0.6× 3.3k 1.9× 1.1k 0.8× 1.3k 1.0× 729 1.1× 167 5.8k
Gary D. Grossfeld United States 48 1.9k 0.7× 3.4k 2.0× 1.1k 0.8× 1.4k 1.0× 662 1.0× 123 6.0k
Christer Busch Sweden 33 2.6k 1.0× 3.5k 2.0× 1.3k 0.9× 1.3k 1.0× 621 0.9× 106 6.8k
Armen Aprikian Canada 48 3.0k 1.2× 4.2k 2.4× 2.2k 1.6× 2.0k 1.5× 1.4k 2.0× 279 8.7k

Countries citing papers authored by Karim Chamie

Since Specialization
Citations

This map shows the geographic impact of Karim Chamie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim Chamie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim Chamie more than expected).

Fields of papers citing papers by Karim Chamie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karim Chamie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim Chamie. The network helps show where Karim Chamie may publish in the future.

Co-authorship network of co-authors of Karim Chamie

This figure shows the co-authorship network connecting the top 25 collaborators of Karim Chamie. A scholar is included among the top collaborators of Karim Chamie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karim Chamie. Karim Chamie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bailey, Adrian J., Lorna Kwan, Jeremy B. Shelton, et al.. (2025). Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration. Cancer. 131(15). e70007–e70007.
2.
Zhang, JJ H., Daniel Joyce, Yong Shan, et al.. (2025). National complication and cost burden of transurethral resection of bladder tumor for bladder cancer. Urologic Oncology Seminars and Original Investigations. 43(8). 469.e1–469.e11. 1 indexed citations
3.
Sonpavde, Guru, Begoña P. Valderrama, Karim Chamie, et al.. (2025). Phase 1/2 INTerpath-005 study: V940 (mRNA-4157) plus pembrolizumab with or without enfortumab vedotin (EV) for resected high-risk muscle-invasive urothelial carcinoma (MIUC).. Journal of Clinical Oncology. 43(5_suppl). 2 indexed citations
4.
Soon‐Shiong, Patrick, Sandeep K. Reddy, & Karim Chamie. (2024). MP16-03 N-803 PLUS BCG COMPLETE RESPONSE RATE IN NMIBC CIS SUBJECTS: BCG REFRACTORY, RELAPSED, CHECKPOINT FAILURE, AND CHEMOTHERAPY FAILURE; UPDATED RESULTS (QUILT 3.032). The Journal of Urology. 211(5S). 2 indexed citations
5.
Zhang, JJ H., et al.. (2023). Novel Delivery Mechanisms for Existing Systemic Agents and Emerging Therapies in Bladder Cancer. Bladder Cancer. 9(2). 109–123. 1 indexed citations
6.
Lec, Patrick M., et al.. (2023). Readmissions after radical nephrectomy in a national cohort. Scandinavian Journal of Urology. 57(1-6). 75–80.
7.
Martin, Ting, Leslie K. Ballas, Holly Wilhalme, et al.. (2022). Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial. International Journal of Radiation Oncology*Biology*Physics. 115(1). 142–152. 31 indexed citations
8.
Fero, Katherine E., Yong Shan, Patrick M. Lec, et al.. (2021). Treatment Patterns, Outcomes, and Costs Associated With Localized Upper Tract Urothelial Carcinoma. JNCI Cancer Spectrum. 5(6). 5 indexed citations
9.
Lec, Patrick M., Andrew T. Lenis, Wayne Brisbane, et al.. (2020). Trends in palliative care interventions among patients with advanced bladder, prostate, or kidney cancer: A retrospective cohort study. Urologic Oncology Seminars and Original Investigations. 38(11). 854.e1–854.e9. 13 indexed citations
10.
Lenis, Andrew T., Vishnukamal Golla, Aydin Pooli, et al.. (2019). Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus—Trends and effect on overall survival. Urologic Oncology Seminars and Original Investigations. 37(9). 577.e9–577.e16. 14 indexed citations
11.
Faiena, Izak, et al.. (2018). Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma. Drug Design Development and Therapy. Volume 12. 209–215. 35 indexed citations
12.
Pooli, Aydin, Amirali Salmasi, Izak Faiena, et al.. (2018). Variation in surgical treatment patterns for patients with prostate cancer in the United States: Do patients in academic hospitals fare better?. Urologic Oncology Seminars and Original Investigations. 37(1). 63–70. 4 indexed citations
13.
Salmasi, Amirali, Izak Faiena, Andrew T. Lenis, et al.. (2018). Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 36(12). 527.e13–527.e19. 17 indexed citations
14.
Salmasi, Amirali, Izak Faiena, Anthony Sisk, et al.. (2018). Radical prostatectomy then and now: Surgical overtreatment of prostate cancer is declining from 2009 to 2016 at a tertiary referral center. Urologic Oncology Seminars and Original Investigations. 36(9). 401.e19–401.e25. 6 indexed citations
15.
Huo, Jinhai, Yiyi Chu, Karim Chamie, et al.. (2017). Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder Cancer. Clinical Genitourinary Cancer. 16(1). e99–e111. 8 indexed citations
16.
Packiam, Vignesh T., Donald L. Lamm, Daniel A. Barocas, et al.. (2017). An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results. Urologic Oncology Seminars and Original Investigations. 36(10). 440–447. 190 indexed citations
17.
Zimmermann, Maike, Hongyong Zhang, Michael Malfatti, et al.. (2016). Microdose-Induced Drug–DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice. Molecular Cancer Therapeutics. 16(2). 376–387. 22 indexed citations
18.
Belldegrun, Arie S., Karim Chamie, Paul Bevan, et al.. (2013). ARISER: A randomized double blind phase III study to evaluate adjuvant cG250 treatment versus placebo in patients with high-risk ccRCC—Results and implications for adjuvant clinical trials.. Journal of Clinical Oncology. 31(15_suppl). 4507–4507. 37 indexed citations
19.
Bergman, Jonathan, Karim Chamie, Charles D. Scales, et al.. (2013). Building a Medical Neighborhood in the Safety Net: An Innovative Technology Improves Hematuria Workups. Urology. 82(6). 1277–1282. 18 indexed citations
20.
Bedolla, Roble, Yu Wang, Karim Chamie, et al.. (2009). Nuclear versus Cytoplasmic Localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with Metastases. Clinical Cancer Research. 15(3). 788–796. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Tanguay Breakdown of academic impact, for papers by Howard Kynaston Breakdown of academic impact, for papers by C.C. Abbou Breakdown of academic impact, for papers by Louis Denis Breakdown of academic impact, for papers by Robert S. Svatek Breakdown of academic impact, for papers by Theresa M. Koppie Breakdown of academic impact, for papers by Gabriel P. Haas Breakdown of academic impact, for papers by Gary D. Grossfeld Breakdown of academic impact, for papers by Christer Busch Breakdown of academic impact, for papers by Armen Aprikian
Rankless by CCL
2026